How is chronic pharyngitis with excessive white, sticky sputum treated?
Chronic pharyngitis characterized by excessive production of thick, white, mucoid sputum often reflects persistent inflammation of the pharyngeal mucosa—commonly driven by postnasal drip, gastroesophageal reflux disease (GERD), chronic sinusitis, or prolonged environmental irritant exposure (e.g., dry air, tobacco smoke, or occupational pollutants). The “white sticky phlegm” is typically composed of desquamated epithelial cells, inflammatory exudate, and viscous mucus hypersecreted by hypertrophied submucosal glands.
Effective management requires identifying and addressing underlying contributors. A thorough evaluation should include assessment for allergic rhinitis, laryngopharyngeal reflux (LPR), nasal septal deviation, or silent GERD—even in the absence of classic heartburn. Nasolaryngoscopy may reveal cobblestoning of the posterior pharynx, mucosal edema, or pooling of secretions, supporting a diagnosis of reflux- or allergy-related etiology.
First-line nonpharmacologic strategies include strict allergen avoidance, nasal saline irrigation (e.g., twice-daily low-pressure pulsatile irrigation), humidification of indoor air (ideally 40–60% relative humidity), and strict adherence to reflux precautions: elevating the head of the bed, avoiding meals within 3 hours of bedtime, eliminating caffeine, alcohol, chocolate, and acidic foods, and maintaining a healthy weight. Smoking cessation is mandatory if applicable.
Pharmacotherapy is tailored to the dominant mechanism. For postnasal drip due to allergic or nonallergic rhinitis, intranasal corticosteroids (e.g., mometasone or fluticasone) are first-line; adjunctive oral second-generation antihistamines (e.g., loratadine or fexofenadine) may be added if symptoms persist. For suspected LPR, empiric high-dose proton pump inhibitor (PPI) therapy (e.g., esomeprazole 40 mg twice daily) for 3 months—taken 30–60 minutes before breakfast and dinner—is recommended, alongside pH-metry or impedance testing if response is suboptimal. Mucolytics such as erdosteine or N-acetylcysteine may be considered off-label for refractory mucous viscosity, though evidence remains limited.
Antibiotics have no role in uncomplicated chronic pharyngitis unless acute bacterial sinusitis or streptococcal infection is confirmed microbiologically—chronic mucoid sputum alone does not indicate bacterial infection. Persistent or worsening symptoms despite 3–6 months of optimized conservative management warrant referral to an otolaryngologist for further workup, including possible imaging (e.g., sinus CT) or biopsy to exclude granulomatous, autoimmune, or neoplastic conditions.